GSK’s Jideytro Shows 94% Response in ROS1 Lung Cancer
London, United Kingdom, September 13, 2026 GSK has announced positive registrational data from the Phase I/II ARROS-1 trial supporting...
GSK
Advertisement
GSK Shingrix Prefilled Syringe Approved in Japan
London, United Kingdom, September 10, 2026 GSK has announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has...
GSK Files EU Submission for Lower-Carbon Ventolin
London, UK, September 7, 2026 GSK plc has submitted a regulatory application in the European Union for a next-generation,...
XYRA Doses First European Patient in Budiodarone Trial
BASEL, Switzerland, Aug. 31, 2026 XYRA LLC announced that the first patient in Europe has been dosed in the...
Kyowa Kirin Reaches U.S. Agreement to Lower Medicine Costs
TOKYO, Japan and PRINCETON, New Jersey, Aug. 31/Sept. 1, 2026 Kyowa Kirin Co., Ltd. announced a voluntary agreement with...
Advertisements
GSK Advances mRNA Flu Vaccine to Phase III After Data
LONDON, UK, Sept. 1, 2026 GSK announced that it will advance its investigational mRNA seasonal influenza vaccine candidate into...
GSK Wins Japan Approval for Hibsago in Hepatitis B
LONDON, UK, Aug 24, 2026 GSK plc announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved...
ViiV Healthcare’s Tivicay PD Wins FDA Approval for Kids
LONDON, Aug 26, 2026 The U.S. Food and Drug Administration (FDA) has approved Tivicay PD (dolutegravir) from ViiV Healthcare...
Apertura Reports Progress in AAV Gene Therapy for TSC1
SILVER SPRING, Md. and NEW YORK, July 30, 2026 The TSC Alliance and Apertura Gene Therapy have announced the...
Relation and GSK Expand $110M AI Drug Discovery Alliance
LONDON, July 30, 2026 Relation Therapeutics has announced an expanded strategic collaboration with GSK that will accelerate the use...
Advertisement
